17,605 research outputs found

    Collisions of small ice particles under microgravity conditions (II): Does the chemical composition of the ice change the collisional properties?

    Get PDF
    Context: Understanding the collisional properties of ice is important for understanding both the early stages of planet formation and the evolution of planetary ring systems. Simple chemicals such as methanol and formic acid are known to be present in cold protostellar regions alongside the dominant water ice; they are also likely to be incorporated into planets which form in protoplanetary disks, and planetary ring systems. However, the effect of the chemical composition of the ice on its collisional properties has not yet been studied. Aims: Collisions of 1.5 cm ice spheres composed of pure crystalline water ice, water with 5% methanol, and water with 5% formic acid were investigated to determine the effect of the ice composition on the collisional outcomes. Methods: The collisions were conducted in a dedicated experimental instrument, operated under microgravity conditions, at relative particle impact velocities between 0.01 and 0.19 m s^-1, temperatures between 131 and 160 K and a pressure of around 10^-5 mbar. Results: A range of coefficients of restitution were found, with no correlation between this and the chemical composition, relative impact velocity, or temperature. Conclusions: We conclude that the chemical composition of the ice (at the level of 95% water ice and 5% methanol or formic acid) does not affect the collisional properties at these temperatures and pressures due to the inability of surface wetting to take place. At a level of 5% methanol or formic acid, the structure is likely to be dominated by crystalline water ice, leading to no change in collisional properties. The surface roughness of the particles is the dominant factor in explaining the range of coefficients of restitution

    Equation modifying program, L219 (EQMOD). Volume 1: Engineering and usage

    Get PDF
    The analysis and use of the Equation Modifying Program (EQMOD) L219, digital computer program which modifies matrices according to specific instructions was described. The program modifies the theoretical equation of motion and load equations generated by the DYLOFLEX programs Equation of Motion L217 (EOM), and Load Equations, L218 (LOADS), respectively

    Method of statistical filtering

    Get PDF
    Minimal formula for bounding the cross correlation between a random forcing function and the state error when this correlation is unknown is used in optimal linear filter theory applications. Use of the bound results in overestimation of the estimation-error covariance

    Soft-tissue specimens from pre-European extinct birds of New Zealand

    Get PDF
    We provide the first complete review of soft tissue remains from New Zealand birds that became extinct prior to European settlement (c. AD 1800). These rare specimens allow insights into the anatomy and appearance of the birds that are not attainable from bones. Our review includes previously unpublished records of ‘lost’ specimens, and descriptions of recently discovered specimens such as the first evidence of soft tissues from the South Island goose (Cnemiornis calcitrans). Overall, the soft tissue remains are dominated by moa (with specimens from each of the six genera), but also include specimens from Finsch's duck (Chenonetta finschi) and the New Zealand owlet-nightjar (Aegotheles novaezealandiae). All desiccated soft tissue specimens that have radiocarbon or stratigraphic dates are late Holocene in age, and most have been found in the semi-arid region of Central Otago

    Axisymmetric filamentary structures

    Get PDF
    Axisymmetric filamentary structure

    Teaching Excellence: A Reaction to the Smith Commission Report and its Effects

    Get PDF
    This paper has been written partially in response to the Smith Commission Report, and partially in response to the reactions the report has elicited already. The Smith Commission Report voiced many valid concerns about teaching excellence; however, many of the so-called "innovations" that have been developed in answer to Stuart Smith's call for teaching excellence are, in fact, little different from those techniques implemented under the auspices of the Ontario Universities Program for Institutional Development (OUPID) in the 1960's and early 1970's. This being the case, the authors feel that the most likely result will be a similar lack of success. It is, therefore, our suggestion that an attempt ought to be made to change the infrastructure of the university sys- tem so that it supports good teaching and research with equal measure. This, above all else, should lead to real improvements in the quality of teaching

    Effect of folic acid supplementation in pregnancy on preeclampsia: The folic acid clinical trial study

    Get PDF
    Copyright © 2013 Shi Wu Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Preeclampsia (PE) is hypertension with proteinuria that develops during pregnancy and affects at least 5% of pregnancies. The Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia: the Folic Acid Clinical Trial (FACT) aims to recruit 3,656 high risk women to evaluate a new prevention strategy for PE: supplementation of folic acid throughout pregnancy. Pregnant women with increased risk of developing PE presenting to a trial participating center between 80/7 and 166/7 weeks of gestation are randomized in a 1: 1 ratio to folic acid 4.0 mg or placebo after written consent is obtained. Intent-to-treat population will be analyzed. The FACT study was funded by the Canadian Institutes of Health Research in 2009, and regulatory approval from Health Canada was obtained in 2010. A web-based randomization system and electronic data collection system provide the platform for participating centers to randomize their eligible participants and enter data in real time. To date we have twenty participating Canadian centers, of which eighteen are actively recruiting, and seven participating Australian centers, of which two are actively recruiting. Recruitment in Argentina, UK, Netherlands, Brazil, West Indies, and United States is expected to begin by the second or third quarter of 2013. This trial is registered with NCT01355159. © 2013 Shi Wu Wen et al.The Canadian Institutes of Healt

    Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.

    Get PDF
    BackgroundOnly Clostridium botulinum strain IBCA10-7060 produces the recently described novel botulinum neurotoxin type H (BoNT/H). BoNT/H (N-terminal two-thirds most homologous to BoNT/F and C-terminal one-third most homologous to BoNT/A) requires antitoxin to toxin ratios ≥1190:1 for neutralization by existing antitoxins. Hence, more potent and safer antitoxins against BoNT/H are needed.MethodsWe therefore evaluated our existing monoclonal antibodies (mAbs) to BoNT/A and BoNT/F for BoNT/H binding, created yeast-displayed mutants to select for higher-affinity-binding mAbs by using flow cytometry, and evaluated the mAbs' ability to neutralize BoNT/H in the standard mouse bioassay.ResultsAnti-BoNT/A HCC-binding mAbs RAZ1 and CR2 bound BoNT/H with high affinity. However, only 1 of 6 BoNT/F mAbs (4E17.2A) bound BoNT/H but with an affinity >800-fold lower (equilibrium dissociation binding constant [KD] = 7.56 × 10(-8)M) than its BoNT/F affinity (KD= 9.1 × 10(-11)M), indicating that the N-terminal two-thirds of BoNT/H is immunologically unique. The affinity of 4E17.2A for BoNT/H was increased >500-fold to KD= 1.48 × 10(-10)M (mAb 4E17.2D). A combination of mAbs RAZ1, CR2, and 4E17.2D completely protected mice challenged with 280 mouse median lethal doses of BoNT/H at a mAb dose as low as 5 µg of total antibody.ConclusionsThis 3-mAb combination potently neutralized BoNT/H and represents a potential human antitoxin that could be developed for the prevention and treatment of type H botulism
    corecore